Close Menu

Mike Nolan

Freenome has hired Mike Nolan as its chief commercial officer. In his new position, Nolan will be responsible for bringing Freenome's first AI-generated, genomic cancer screening test, a blood test for colorectal cancer, to market. Most recently, Nolan was senior vice president of commercial operations at Foundation Medicine. Overall, he has more than 25 years of experience in strategic management and commercial leadership at companies such as Thermo Fisher Scientific, Life Technologies, Luminex, and Roche Diagnostics.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.